Lipid–Polymer Hybrid Nanoparticles as a Next-Generation Drug Delivery Platform

State of the Art, Emerging Technologies, and Perspectives

Venkata Maidhar Yenugonda, M.Phil, Ph.D., Associate Professor in the Department of Translational Neurosciences and Neurotherapeutics, and Director of Drug Discovery and Nanomedicine Research Program at the John Wayne Cancer Institute, published the article, Lipid–Polymer Hybrid Nanoparticles as a Next-Generation Drug Delivery Platform: State of the Art, Emerging Technologies, and Perspectives, in the International Journal of Nanomedicine.

Research Program Fact Sheet

The Drug Discovery and Nanomedicine (DDNM) Research Program at JWCI fosters the development of novel, safe and effective therapeutics for both oral and intravenous delivery, to address the unmet disease needs in oncology and the neurosciences.

Donations:

If you would like to make donations, Please make checks payable  to:

JWCI DDNM Research Program
2200 Santa Monica Blvd
Santa Monica, CA-90404

Career Opportunity:

The DDNM research program is always looking for talented and enthusiastic individuals at all levels who are interested in becoming a part of our team developing new therapeutics for unmet medical needs.

If you would like to join our team, please send your cover letter and curriculum vitae to:

Contact Us

Visit our Careers Page

Team working together in drug discovery and nanomedicines